BAIRD MEDICAL INVESTMENT HOL
BDMDNASDAQ🏆 #3506 by market capUS Equity
$1.17▼ $0.05 (−4.10%)
Market closed · at close1h—
24h▼ 4.1%
7d▲ 9.9%
14d▲ 12.0%
30d▲ 2.6%
1y▼ 51.2%
🏦Market Cap
$49M
Small Cap
📈Revenue Growth (YoY)
-39.1%
Declining
📊Gross Margin
83.8%
High
💵FCF Margin
-6.2%
Thin
⚖️P/S Ratio
2.2x
Cheap
Otter Score
52
Weak
Trading Snapshot
- Day Range
- $1.16 – $1.18
- 52-Week Range
- $0.76 – $3.75
- Volume
- $2.72B
- Avg Volume
- $2.43B
- Shares Outstanding
- 42.2M
- Next Earnings
- Oct 8, 2026
Fundamentals Snapshot
- Annual Revenue
- $23M
- Last Q Revenue
- $15M
- P/E Ratio
- -1.2
- P/S Ratio
- 2.2x
- EPS (TTM)
- $-0.94
- Dividend Yield
- 0.00%
Why Investors Own BDMD
- ✓High-growth profile — revenue up +43.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 52% gross margin and 23% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$23M▲ +47.4% YoY
Gross Margin (TTM)
51.5%▲ +4.0% YoY
Operating Income (TTM)
$8M▲ +47.4% YoY
Free Cash Flow (TTM)
$5M▲ +47.4% YoY
About BAIRD MEDICAL INVESTMENT HOL
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
52/100
Analyst Price Target
ⓘAverage Target
$1.41
▲ +20.7% Upside
High Target$1.76
Low Target$1.17
Based on 41 analysts